Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury

Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):675-684. doi: 10.1161/ATVBAHA.117.308992. Epub 2017 Feb 2.

Abstract

Objective: Phenotypic modulation of vascular smooth muscle cells represents a hallmark event in vascular injury. The underlying mechanism is not completely sorted out. We investigated the involvement of angiogenic factor with G patch and FHA domains 1 (Aggf1) in vascular injury focusing on the transcriptional regulation of vascular smooth muscle cell signature genes.

Approach and results: We report here that Aggf1 expression was downregulated in several different cell models of phenotypic modulation in vitro and in the vessels after carotid artery ligation in mice. Adenovirus-mediated Aggf1 overexpression dampened vascular injury and normalized vascular smooth muscle cell signature gene expression. Mechanistically, Aggf1 interacted with myocardin and was imperative for the formation of a serum response factor-myocardin complex on gene promoters. In response to injurious stimuli, kruppel-like factor 4 was recruited to the Aggf1 promoter and enlisted histone deacetylase 11 to repress Aggf1 transcription. In accordance, depletion of kruppel-like factor 4 or histone deacetylase 11 restored Aggf1 expression and abrogated vascular smooth muscle cell phenotypic modulation. Finally, treatment of a histone deacetylase 11 inhibitor attenuated vascular injury in mice.

Conclusions: Therefore, we have unveiled a previously unrecognized role for Aggf1 in regulating vascular injury.

Keywords: carotid arteries; epigenetics; histone deacetylases; muscle, smooth, vascular; serum response factor.

MeSH terms

  • Angiogenic Proteins / genetics
  • Angiogenic Proteins / metabolism*
  • Animals
  • Carotid Artery Injuries / genetics
  • Carotid Artery Injuries / metabolism*
  • Carotid Artery Injuries / pathology
  • Carotid Artery Injuries / prevention & control
  • Cell Line
  • Disease Models, Animal
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylases / genetics
  • Histone Deacetylases / metabolism
  • Humans
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors / genetics
  • Kruppel-Like Transcription Factors / metabolism
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Muscle, Smooth, Vascular / pathology
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism*
  • Myocytes, Smooth Muscle / pathology
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Phenotype
  • RNA Interference
  • Rats, Sprague-Dawley
  • Serum Response Factor / genetics
  • Serum Response Factor / metabolism
  • Signal Transduction
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Transfection

Substances

  • AGGF1 protein, human
  • AGGF1 protein, rat
  • Angiogenic Proteins
  • Histone Deacetylase Inhibitors
  • KLF4 protein, human
  • Klf4 protein, mouse
  • Klf4 protein, rat
  • Kruppel-Like Factor 4
  • Kruppel-Like Transcription Factors
  • Nuclear Proteins
  • SRF protein, human
  • Serum Response Factor
  • Trans-Activators
  • myocardin
  • HDAC11 protein, human
  • Histone Deacetylases